Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Brain Research|May 8, 1989
Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structuresM Cador, J M Rivet, A E Kelley, et al.
European Journal of Pharmacology|November 24, 1994
Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297J M Rivet, V Audinot, A Gobert, et al.
Brain Research|March 31, 1987
Spontaneous and graft-induced behavioral recovery after 6-hydroxydopamine lesion of the nucleus accumbens in the ratK Choulli, J P Herman, J M Rivet, et al.
Neuropsychobiology|January 1, 1986
Locomotor activity in relation to dopamine and noradrenaline in the nucleus accumbens, septal and frontal areas: a 6-hydroxydopamine studyR D Oades, K Taghzouti, J M Rivet, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 20, 2000
Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agentsM J Millan, A Gobert, K Bervoets, et al.
European Journal of Pharmacology|July 21, 1994
Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptorsF Lejeune, V Audinot, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 28, 2000
S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626M J Millan, A Dekeyne, J M Rivet, et al.
European Journal of Pharmacology|October 15, 1991
S 14671: a novel naphthylpiperazine 5-HT1A agonist of high efficacy and exceptional in vivo potencyM J Millan, H Canton, J M Rivet, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonistsM J Millan, J M Rivet, H Canton, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigmM J Millan, J M Rivet, A Gobert, et al.
Pageof 6